IceCure Medical Ltd (ICCM)
USD 1.13
(-1.74%)
USD 1.13
(-1.74%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 16.41 Million USD | -45.64% |
| 2022 | 30.18 Million USD | -6.48% |
| 2021 | 32.28 Million USD | 212.28% |
| 2020 | 10.33 Million ILS | 41.27% |
| 2019 | 7.31 Million ILS | 39.27% |
| 2018 | 5.25 Million ILS | 172.07% |
| 2017 | 1.93 Million ILS | -41.71% |
| 2016 | 3.31 Million ILS | -34.43% |
| 2015 | 5.05 Million ILS | 52.82% |
| 2014 | 3.3 Million ILS | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 15.31 Million USD | -3.45% |
| 2024 Q1 | 15.9 Million USD | -2.25% |
| 2023 Q4 | 16.27 Million USD | -16.2% |
| 2023 FY | 16.41 Million USD | -45.64% |
| 2023 Q2 | 22.69 Million USD | -15.57% |
| 2023 Q1 | 26.87 Million USD | -10.96% |
| 2023 Q3 | 19.42 Million USD | -14.42% |
| 2022 Q1 | 28.7 Million USD | -11.07% |
| 2022 FY | 30.18 Million USD | -6.48% |
| 2022 Q3 | 20.09 Million USD | -15.62% |
| 2022 Q4 | 30.18 Million USD | 50.23% |
| 2022 Q2 | 23.81 Million USD | -17.05% |
| 2021 FY | 32.28 Million USD | 212.28% |
| 2021 Q3 | 63.44 Million USD | -10.16% |
| 2021 Q4 | 32.28 Million USD | -49.12% |
| 2021 Q2 | 70.61 Million USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q3 | - USD | -100.0% |
| 2020 Q4 | 10.33 Million ILS | 0.0% |
| 2020 FY | 10.33 Million ILS | 41.27% |
| 2020 Q1 | 25.14 Million USD | 243.58% |
| 2020 Q2 | 7.28 Million ILS | -71.01% |
| 2019 Q4 | 7.31 Million ILS | -71.12% |
| 2019 FY | 7.31 Million ILS | 39.27% |
| 2019 Q1 | 16.42 Million USD | 212.57% |
| 2019 Q2 | 4.59 Million ILS | -72.02% |
| 2019 Q3 | 25.33 Million USD | 451.41% |
| 2018 Q4 | 5.25 Million ILS | -76.66% |
| 2018 Q2 | 6.75 Million ILS | -72.66% |
| 2018 Q1 | 24.72 Million USD | 1180.51% |
| 2018 Q3 | 22.51 Million USD | 233.05% |
| 2018 FY | 5.25 Million ILS | 172.07% |
| 2017 FY | 1.93 Million ILS | -41.71% |
| 2017 Q1 | 10.01 Million USD | 202.31% |
| 2017 Q4 | 1.93 Million ILS | -78.54% |
| 2017 Q2 | 2.87 Million ILS | -71.33% |
| 2017 Q3 | 9 Million USD | 213.46% |
| 2016 Q3 | 4.18 Million USD | 27.4% |
| 2016 Q4 | 3.31 Million ILS | -20.8% |
| 2016 FY | 3.31 Million ILS | -34.43% |
| 2016 Q2 | 3.28 Million USD | -23.23% |
| 2016 Q1 | 4.27 Million USD | -15.61% |
| 2015 FY | 5.05 Million ILS | 52.82% |
| 2015 Q3 | 6.02 Million USD | -15.82% |
| 2015 Q2 | 7.15 Million USD | -2.42% |
| 2015 Q1 | 7.33 Million USD | -43.0% |
| 2015 Q4 | 5.06 Million USD | -15.9% |
| 2014 FY | 3.3 Million ILS | 0.0% |
| 2014 Q4 | 12.87 Million USD | -0.76% |
| 2014 Q3 | 12.97 Million USD | -20.59% |
| 2014 Q2 | 16.33 Million USD | -17.17% |
| 2014 Q1 | 19.72 Million USD | -15.12% |
| 2013 Q1 | 9.71 Million USD | 0.56% |
| 2013 Q2 | 13.75 Million USD | 41.57% |
| 2013 Q3 | 27.07 Million USD | 96.87% |
| 2013 Q4 | 23.23 Million USD | -14.2% |
| 2012 Q4 | 9.66 Million USD | -26.32% |
| 2012 Q3 | 13.11 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| PetVivo Holdings, Inc. | 3.11 Million USD | -426.763% |
| Talis Biomedical Corporation | 98.34 Million USD | 83.313% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -113.339% |
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 47.682% |
| Bioventus Inc. | 810.91 Million USD | 97.976% |
| Cerus Corporation | 197.74 Million USD | 91.702% |
| CVRx, Inc. | 115.22 Million USD | 85.759% |
| electroCore, Inc. | 16.38 Million USD | -0.14% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 72.026% |
| OrthoPediatrics Corp. | 449.58 Million USD | 96.35% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 39.824% |
| Spectral AI, Inc. | 10.69 Million USD | -53.479% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 1.019% |
| BrainsWay Ltd. | 62.97 Million USD | 73.941% |
| Envoy Medical, Inc. | 7.64 Million USD | -114.791% |
| MaxCyte, Inc. | 268.27 Million USD | 93.883% |
| NanoVibronix, Inc. | 6.67 Million USD | -145.88% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 92.495% |
| Nexalin Technology, Inc. | 3.63 Million USD | -351.828% |
| Orthofix Medical Inc. | 925.31 Million USD | 98.227% |
| Inogen, Inc. | 326.19 Million USD | 94.969% |
| PAVmed Inc | 33.11 Million USD | 50.451% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 29.867% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 88.561% |
| RxSight, Inc. | 182.55 Million USD | 91.011% |
| Sight Sciences, Inc. | 166.65 Million USD | 90.153% |
| SI-BONE, Inc. | 230.42 Million USD | 92.878% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -102.66% |
| TELA Bio, Inc. | 78.04 Million USD | 78.974% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 36.21% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 93.486% |
| Venus Concept Inc. | 93.65 Million USD | 82.478% |
| Acutus Medical, Inc. | 53.96 Million USD | 69.589% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -52.936% |
| LivaNova PLC | 2.42 Billion USD | 99.325% |
| 908 Devices Inc. | 202.98 Million USD | 91.915% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 97.962% |
| Nemaura Medical Inc. | 14.56 Million USD | -12.681% |
| NeuroPace, Inc. | 107.65 Million USD | 84.756% |
| LENSAR, Inc. | 69.58 Million USD | 76.417% |
| Apyx Medical Corporation | 79.24 Million USD | 79.291% |
| Cutera, Inc. | 346.29 Million USD | 95.261% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 60.943% |
| BioSig Technologies, Inc. | 1.79 Million USD | -812.681% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 93.936% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 61.534% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.566% |
| Axonics, Inc. | 719.92 Million USD | 97.721% |
| Outset Medical, Inc. | 313.8 Million USD | 94.771% |
| IRIDEX Corporation | 34.43 Million USD | 52.346% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 95.945% |
| IRadimed Corporation | 92.15 Million USD | 82.193% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -212.333% |
| INVO Bioscience, Inc. | 20.88 Million USD | 21.437% |
| Telesis Bio, Inc. | 70.41 Million USD | 76.694% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 89.351% |
| Varex Imaging Corporation | 1.24 Billion USD | 98.687% |
| Quipt Home Medical Corp. | 247.4 Million USD | 93.367% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -76.262% |
| Pulmonx Corporation | 178.95 Million USD | 90.83% |
| Dynatronics Corporation | 25.94 Million USD | 36.74% |
| Modular Medical, Inc. | 13.8 Million USD | -18.853% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -52.978% |
| Semler Scientific, Inc. | 78.06 Million USD | 78.979% |
| InMode Ltd. | 863.28 Million USD | 98.099% |
| Bruker Corporation | 4.24 Billion USD | 99.614% |
| Cytosorbents Corporation | 53.26 Million USD | 69.189% |
| DexCom, Inc. | 6.26 Billion USD | 99.738% |
| Align Technology, Inc. | 6.08 Billion USD | 99.73% |
| Viveve Medical, Inc. | 25.91 Million USD | 36.673% |
| ZimVie Inc. | 1.2 Billion USD | 98.639% |
| Movano Inc. | 9.42 Million USD | -74.185% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 96.703% |
| Nexalin Technology, Inc. | 3.63 Million USD | -351.828% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 72.026% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 98.277% |
| Profound Medical Corp. | 43.68 Million USD | 62.437% |
| Insulet Corporation | 2.58 Billion USD | 99.366% |
| enVVeno Medical Corporation | 48.63 Million USD | 66.259% |
| Surmodics, Inc. | 185.73 Million USD | 91.165% |
| iCAD, Inc. | 41.41 Million USD | 60.38% |
| Nuwellis, Inc. | 9.77 Million USD | -67.963% |
| Biotricity, Inc. | 5.94 Million USD | -176.141% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 96.211% |
| Aethlon Medical, Inc. | 8.24 Million USD | -99.006% |
| InspireMD, Inc. | 47.64 Million USD | 65.556% |
| PAVmed Inc. | 33.11 Million USD | 50.451% |
| BIOLASE, Inc. | 35.1 Million USD | 53.249% |
| Beyond Air, Inc. | 56.96 Million USD | 71.191% |
| FONAR Corporation | 214.24 Million USD | 92.341% |
| AxoGen, Inc. | 196.82 Million USD | 91.663% |
| Vivani Medical, Inc. | 45.79 Million USD | 64.168% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 94.169% |
| Inari Medical, Inc. | 674.23 Million USD | 97.566% |
| UFP Technologies, Inc. | 404.13 Million USD | 95.939% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -72.68% |
| Tenon Medical, Inc. | 6.34 Million USD | -158.629% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -74.445% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 84.168% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.645% |
| Sintx Technologies, Inc. | 15.36 Million USD | -6.801% |
| Quanterix Corporation | 425.01 Million USD | 96.139% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -76.262% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 69.457% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.06% |
| TransMedics Group, Inc. | 706.04 Million USD | 97.676% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 74.032% |
| NeuroMetrix, Inc. | 21.42 Million USD | 23.405% |
| Hyperfine, Inc. | 94.19 Million USD | 82.579% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 93.891% |
| Biomerica, Inc. | 9.25 Million USD | -77.329% |
| Bone Biologics Corporation | 3.73 Million USD | -339.033% |
| AVITA Medical, Inc. | 144.33 Million USD | 88.631% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -237.063% |
| Silk Road Medical, Inc | 265.3 Million USD | 93.815% |